Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Italy
    2026 VAC US SMFM Maternal RSV QI
    Release Date:
    Partner: Society for Maternal Fetal Medicine
    Review Process: Expert Review Panel
    Quality Improvement Vaccines USA
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Expert Review Panel
    Education Oncology All
    Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting Professorship
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology USA
    New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom
    Guideline Concordant Care and New Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Establishing Concordance in Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Cognition of the Significance of Vaccination and Advancement in Accessibility
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promoting Understanding and Improving Practices Related to Post-COVID-19 Symptoms
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Japan
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Optimizing Maternal Immunization Practice in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Vaccines Canada
    Patient Preferences for Drug Delivery: Literature Review
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Global Awards for Research in DMD-AWARD
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Rare Disease Canada
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, India, Saudi Arabia, Singapore, Taiwan, Turkey
    Invasive Fungal Infections (Global excluding US)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Early Identification and Diagnosis of Non-Alcoholic Steatohepatitis (NASH) in At-Risk Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Advances in Migraine Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA